Shirsa Udgata

6PUBLICATIONS
25CO-AUTHORS
ChemotherapyMolecular targetsMedical biochemistry - lipidsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.

|Nov 27, 2025
Correction: Schmitz et al. The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. Biomedicines 2025, 13, 1319.

Alexa E Schmitz, Shirsa Udgata, Katherine A Johnson

|Sep 17, 2025
The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression.

Fei Sun, Ke Wang, Xingchen Dong

|Sep 08, 2025
Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.

Amani Gillette, Shirsa Udgata, Alexa E Schmitz

|Jun 26, 2025
The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies.

Alexa E Schmitz, Shirsa Udgata, Katherine A Johnson

|Oct 17, 2020
THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.

Shirsa Udgata, Naomi Takenaka, William R Bamlet

Pageof 1

Frequent Collaborators

3 joint publications

Katherine A Johnson

2 joint publications

Jeremy D Kratz

2 joint publications

Dustin A Deming

2 joint publications

Melissa C Skala